Trial intelligence / Profile preview

Irbesartan/Hydrochlorothiazide vs Irbesartan in Mild to Moderate Hypertension

NCT00443612Phase 4Completed

Sponsor
Sanofi
Start
Sep 2006
Primary completion
Oct 2008
Modality
Small Molecules
Countries
1
01

Overview

A Phase 4 trial of irbesartan, hydrochlorothiazide in hypertension (HTN), sponsored by Sanofi. Started Sep 2006; status: completed.

02

Drugs

irbesartanhydrochlorothiazide
03

Conditions

hypertension (HTN)

Beyond the preview

Go deeper on NCT00443612.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00443612.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call